NCT04138186: G-PURĀ® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea |
|
|
| Recruiting | N/A | 30 | Europe | 2.0g G-PURĀ®, oral administration, Placebo, oral administration | Glock Health, Science and Research GmbH | Irritable Bowel Syndrome With Diarrhea (IBS-D) | 02/21 | 02/21 | | |